Guangdong Hybribio Biotech Co Ltd (300639) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.018x

Based on the latest financial reports, Guangdong Hybribio Biotech Co Ltd (300639) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥66.39 Million ≈ $9.71 Million USD) by net assets (CN¥3.73 Billion ≈ $545.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Guangdong Hybribio Biotech Co Ltd for the company's overall valuation and market capitalisation.

Guangdong Hybribio Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Guangdong Hybribio Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guangdong Hybribio Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangdong Hybribio Biotech Co Ltd ranked by their cash flow conversion efficiency. Explore 300639 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Diversified Royalty Corp TO:DIV	0.016x
Daqian Ecology & Landscape Co Ltd SHG:603955	-0.033x
Nanfang Black Sesame Group Co Ltd SHE:000716	0.049x
Rainbow Tours SA WAR:RBW	-0.217x
Endur ASA OL:ENDUR	0.060x
Shandong Haihua Co Ltd SHE:000822	0.007x
Shanghai GuAo Electronic Technology Co Ltd SHE:300551	-0.038x
Jiangsu Yueda Investment Co Ltd SHG:600805	0.002x

Annual Cash Flow Conversion Efficiency for Guangdong Hybribio Biotech Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Guangdong Hybribio Biotech Co Ltd from 2012 to 2025. View Guangdong Hybribio Biotech Co Ltd (300639) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.66 Billion ≈ $535.84 Million	CN¥341.61 Million ≈ $49.99 Million	0.093x	+379.19%
2024-12-31	CN¥4.05 Billion ≈ $592.14 Million	CN¥78.78 Million ≈ $11.53 Million	0.019x	-68.94%
2023-12-31	CN¥5.10 Billion ≈ $746.11 Million	CN¥319.60 Million ≈ $46.77 Million	0.063x	-74.98%
2022-12-31	CN¥5.23 Billion ≈ $764.86 Million	CN¥1.31 Billion ≈ $191.58 Million	0.250x	+37.87%
2021-12-31	CN¥3.48 Billion ≈ $508.50 Million	CN¥631.34 Million ≈ $92.39 Million	0.182x	+47.91%
2020-12-31	CN¥2.53 Billion ≈ $370.84 Million	CN¥311.30 Million ≈ $45.55 Million	0.123x	+28.97%
2019-12-31	CN¥1.18 Billion ≈ $173.35 Million	CN¥112.83 Million ≈ $16.51 Million	0.095x	+27.97%
2018-12-31	CN¥1.08 Billion ≈ $158.05 Million	CN¥80.39 Million ≈ $11.76 Million	0.074x	-8.72%
2017-12-31	CN¥970.90 Million ≈ $142.07 Million	CN¥79.17 Million ≈ $11.58 Million	0.082x	-35.72%
2016-12-31	CN¥501.67 Million ≈ $73.41 Million	CN¥63.63 Million ≈ $9.31 Million	0.127x	+8.26%
2015-12-31	CN¥413.71 Million ≈ $60.54 Million	CN¥48.47 Million ≈ $7.09 Million	0.117x	+16.51%
2014-12-31	CN¥344.60 Million ≈ $50.43 Million	CN¥34.65 Million ≈ $5.07 Million	0.101x	-15.93%
2013-12-31	CN¥191.38 Million ≈ $28.01 Million	CN¥22.89 Million ≈ $3.35 Million	0.120x	-3.12%
2012-12-31	CN¥130.29 Million ≈ $19.06 Million	CN¥16.08 Million ≈ $2.35 Million	0.123x	--

About Guangdong Hybribio Biotech Co Ltd

SHE:300639 China Diagnostics & Research

Market Cap

$558.16 Million

CN¥3.81 Billion CNY

Market Cap Rank

#11779 Global

#3373 in China

Share Price

CN¥5.90

Change (1 day)

+1.72%

52-Week Range

CN¥4.88 - CN¥8.81

All Time High

CN¥19.74